| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/1999 | WO1999017765A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 04/15/1999 | WO1999017764A1 Medicament containing delta-aminolevulinic acid |
| 04/15/1999 | WO1999017763A1 Postsurgical treatment with dichloroacetate |
| 04/15/1999 | WO1999017762A1 Concentrate for medical solution and use thereof |
| 04/15/1999 | WO1999017761A1 Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome x |
| 04/15/1999 | WO1999017760A2 Fungal or mammalian cell efflux pump inhibitors for enhancing susceptibility of the cell to a drug |
| 04/15/1999 | WO1999017759A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 04/15/1999 | WO1999017758A2 Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analgesic drug |
| 04/15/1999 | WO1999017757A1 USE OF P-GLYCOPROTEIN (Pgp) INHIBITORS IN THE TREATMENT OF CANCER |
| 04/15/1999 | WO1999017756A2 Method for preventing transplant rejection |
| 04/15/1999 | WO1999017755A2 Medicaments |
| 04/15/1999 | WO1999017754A1 Dosage form for aerosol administration |
| 04/15/1999 | WO1999017752A1 Improved dosage units |
| 04/15/1999 | WO1999017748A1 Taste masked pharmaceutical compositions |
| 04/15/1999 | WO1999017744A1 Immediate release drug delivery forms |
| 04/15/1999 | WO1999017743A1 Dosage forms having improved release properties |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999017712A2 Tightening and/or reducing the size of body parts containing fat cells |
| 04/15/1999 | WO1999017623A1 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects |
| 04/15/1999 | WO1999017612A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | WO1999011778B1 Antisense treatment of pulmonary hypertension |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999009025A3 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 04/15/1999 | WO1999008668A3 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 04/15/1999 | WO1999008666A3 Pharmaceutical composition comprising an azateroid |
| 04/15/1999 | WO1999007720A3 Process for the purification of acarbose, pharmaceutical composition containing same and its use for the treatment of diabetes |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999005103A3 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent |
| 04/15/1999 | WO1999004821A3 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 04/15/1999 | WO1999004774A3 Nucleotide analog compositions |
| 04/15/1999 | WO1999004773A3 Method for inhibiting bone resorption |
| 04/15/1999 | WO1999004770A3 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 04/15/1999 | WO1999003456A3 Method for prophylaxis or treatment of bone density loss |
| 04/15/1999 | WO1999002666A3 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 04/15/1999 | WO1999002142A3 Novel composition comprising an ssri and a beta-blocker |
| 04/15/1999 | WO1999000399A9 Method of producing tiazofurin and other c-nucleosides |
| 04/15/1999 | WO1998058668A3 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
| 04/15/1999 | WO1998057620B1 Inositol for modulation of immune response |
| 04/15/1999 | WO1998056761A3 Benzimidazole derivatives |
| 04/15/1999 | WO1998055118A3 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | WO1998029110A3 Formulation and method for treating neoplasms by inhalation |
| 04/15/1999 | DE19745146A1 New N-acyl N-acyl-aminoethyl alpha-amino acid derivatives |
| 04/15/1999 | DE19744811A1 Composition for tumour diagnosis and/or therapy |
| 04/15/1999 | DE19744799A1 Combination of endothelin antagonist and diuretic |
| 04/15/1999 | DE19744676A1 Combination product for cancer therapy |
| 04/15/1999 | DE19744459A1 Solubilised silymarin formulation |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | DE19744113A1 Ophthalmological dexamethasone preparation |
| 04/15/1999 | CA2306746A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | CA2306489A1 Benzothiophenes |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2306245A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy |
| 04/15/1999 | CA2306077A1 Novel cycloalkenyl substituted compounds |
| 04/15/1999 | CA2305808A1 Amidocarboxylic acid derivatives |
| 04/15/1999 | CA2305805A1 Compounds and methods |
| 04/15/1999 | CA2305783A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | CA2305751A1 Medicaments |
| 04/15/1999 | CA2305746A1 An efficient method for the conversion of nitriles to amidines |
| 04/15/1999 | CA2305726A1 Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2305538A1 Novel compounds useful as neuro-protective agents |
| 04/15/1999 | CA2305528A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | CA2305414A1 Aryl thiophene derivatives as pde iv inhibitors |
| 04/15/1999 | CA2305413A1 Aryl furan derivatives as pde iv inhibitors |
| 04/15/1999 | CA2305354A1 Methods of treating and preventing endometriosis with phytoestrogens |
| 04/15/1999 | CA2305348A1 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders |
| 04/15/1999 | CA2305342A1 Novel heterocyclic derivatives useful in treating central nervous system disorders |
| 04/15/1999 | CA2305190A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | CA2305182A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | CA2304826A1 5ht4 agonists and antagonists |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304565A1 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 04/15/1999 | CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/15/1999 | CA2304116A1 Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 04/15/1999 | CA2303954A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | CA2303097A1 Polymeric derivatives of camptothecins |
| 04/15/1999 | CA2301569A1 Dosage form for aerosol administration |
| 04/15/1999 | CA2298527A1 Novel dihydronaphthalene compounds and process for producing the same |
| 04/15/1999 | CA2273275A1 Improved dosage units |
| 04/15/1999 | CA2273274A1 Dosage forms having improved release properties |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908518A2 MurE gene encoding uridine-diphosphate-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase of Streptococcus pneumoniae |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908516A1 ABC transporter |
| 04/14/1999 | EP0908467A1 Hot-water extract of ''nemacystis decipiens'' and use thereof |
| 04/14/1999 | EP0908459A1 5-HT4 Agonists and antagonists |
| 04/14/1999 | EP0908458A1 Substituted pyridylmethylpiperazine and -piperidine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 04/14/1999 | EP0908456A1 Pyrazole derivatives, their preparation and their use in drugs |
| 04/14/1999 | EP0908454A2 Oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents |
| 04/14/1999 | EP0908186A2 Method for treating pain |
| 04/14/1999 | EP0908183A1 Dehydroepiandrosterone or derivatives thereof for increasing the content of hyaluronic acid in skin |
| 04/14/1999 | EP0908182A1 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos) |
| 04/14/1999 | EP0908181A1 Remedy for rosacea |
| 04/14/1999 | EP0908180A2 Use of phenyl oxazole or phenyl thiazole derivatives for treating pain |